The Centers for Disease Control and Prevention said a rise in cancer has been tied to the sexually transmitted disease human papillomavirus with throat cancer being the most common.
to the CDC, over 43,000 people were diagnosed with HPV-related cancer
in 2015; in 1999, that number was just 30,000. The CDC also said the
number of people getting the HPV vaccination has also increased,
which can help stem the rise in cancer cases. However, it’s not
increasing fast enough, experts have said.
2017, about half of teenagers 13-17 have gotten their recommended HPV
vaccination doses with two-thirds getting the first dose. This is an
increase of five percentage points from 2016.
MD Anderson Cancer Center president Ronald DePinho said the move is
going in the right direction, but not all parents and health care
providers are giving the children the vaccine, which has been proven
safe and quite effective.
said not getting the vaccine that could prevent cancers is a tragic,
million in the U.S. are infected with the common STD. While most HPV cases clear themselves up, certain HPV strains are persistent and can
lead to cervical, anal, penile, vaginal and throat cancers.
to the agency, 90 percent of HPV-related cancer cases could be
prevented. The vaccine, which was introduced about 10 years ago, has
helped to significantly lower HPV infections and cervical pre-cancer
However, it can take some time before the full benefits of the
vaccine are seen since it takes a few years for several cancers to
develop once HPV has infected someone.
CDC suggests children 11 and 12 get two HPV vaccine doses about six
to 12 months apart. Anyone after 15 years of age should receive three
experts have agreed the rise in HPV vaccination rates is good but
more improvement could be made.
report shows that fewer teenagers living in rural areas are getting
the vaccine and the meningitis vaccine. Also, boys are still less
likely to get the vaccine as girls – with 53 percent of females
compared to 44 percent of males receiving it.
Throat cancer rates in both men and women have risen between 1999 and 2015 with more in men being diagnosed with the disease.